Compare Alcon AG (ALC) vs Nova Ltd (NVMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Nova Ltd — how do they compare? Alcon AG trades at $66.03 (market cap $32.08B), while Nova Ltd trades at $372.02 (market cap $11.83B). The key difference: Alcon AG is far larger — about 2.7× Nova Ltd's market cap, and Alcon AG pays a 0.54% dividend while Nova Ltd pays none. Which is the better fit depends on your goals.
| ALC | NVMI | |
|---|---|---|
Market Cap | $32.08B | $11.83B |
Sector | Health | Technology |
52-Week High | $87.18 | $605.65 |
52-Week Low | $62.02 | $275.78 |
Enterprise Value | $35.92B | $11.61B |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.03, down 0.78% today, with a bearish technical signal from moving averages but bullish oscillators. Revenue grew to $10.40B in 2025, though net income dipped to $980M. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 profit outlook. Analyst consensus is bullish with a $85.85 price target, supported by new product launches and tariff relief.
Outlook is positive due to strong analyst support and operational execution, but risks include intense competition and margin pressure. The stock offers potential upside to the price target, though investors should monitor earnings consistency and macroeconomic headwinds.
Nova Ltd. (NVMI) trades at $372.02, up 1.64% on the day, with a bearish technical signal despite strong fundamentals. The stock shows robust profitability with a 28.84% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news includes a $200 million share repurchase program announced September 2, 2026 (PRNewsWire), signaling management confidence.
The outlook is positive given strong analyst consensus (92.86% buy ratings) and a $527 price target, but high valuation multiples (P/E 46.33) and bearish technical indicators near resistance at $376 present near-term risks. Long-term growth is supported by demand in semiconductor metrology.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Nova Ltd
Nova provides metrology solutions for semiconductor manufacturing. Its systems measure material and process characteristics to help chipmakers control production across advanced nodes and packaging.
Read more on NVMI →
